tykhr
sign in
free sign up
Vanda Pharmaceuticals Inc
Biotechnology
Healthcare
VNDA
58.53 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.73
52 week high
5.46
high
4.88
52 week low
0.00
low
4.73
growth
3.25 %
previous Close
4.75
P/E ratio
market cap
293 M
div yield
0
usd
Mar 2025
qoq
revenue
50.04 M
-5.91 %
net incoming
-29.49 M
-500.45 %
eps
0.00 %
-493.82 %
eps surprise
-1100.00 %
net profit margin
-58.94 %
-49.00 %
operating incoming
-44.55 M
-333.40 %
net change in cash
9.48 M
421.17 %
cash on hand
112 M
9.27 %
cost of revenue
3.52 M
35.95 %
top